Bank Julius Baer & Co’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-548,238
Closed -$32.7M – 848
2021
Q3
$32.7M Buy
548,238
+49,868
+10% +$3.14M 0.2% 85
2021
Q2
$30.9M Buy
498,370
+29,124
+6% +$1.94M 0.2% 93
2021
Q1
$30.6M Buy
469,246
+55,237
+13% +$3.6M 0.23% 89
2020
Q4
$27.2M Buy
414,009
+24,746
+6% +$1.46M 0.22% 84
2020
Q3
$20.1M Buy
389,263
+38,760
+11% +$1.99M 0.2% 92
2020
Q2
$17.3M Buy
350,503
+192,086
+121% +$10.4M 0.2% 91
2020
Q1
$8.07M Buy
+158,417
New +$9.13M 0.19% 90

Other funds holding EHC

Bank Julius Baer & Co's EHC Position: Q4 2021 in Review

Bank Julius Baer & Co sold out of Encompass Health (EHC) in Q4 2021, closing a stake of 548,238 shares — an estimated $32.7M sold.

Bank Julius Baer & Co first reported a position in EHC in Q1 2020 and held it in 7 quarters. The position peaked at $32.7M in Q3 2021. 409 funds tracked by Wall St. Rank hold EHC as of Q4 2021.

  • Bank Julius Baer & Co reported no remaining Encompass Health position as of Q4 2021 after selling out during the quarter.
  • Bank Julius Baer & Co sold 548,238 Encompass Health shares in Q4 2021, an estimated $32.7M.
  • Bank Julius Baer & Co first reported a position in Encompass Health in Q1 2020 and held it in 7 quarters.
  • Bank Julius Baer & Co's Encompass Health position peaked at $32.7M in Q3 2021.
  • 409 funds tracked by Wall St. Rank held Encompass Health as of Q4 2021.

Based on Bank Julius Baer & Co's 13F filing for Q4 2021, filed 15 Feb 2022.